Zydus Cadila has got the USFDA approval for marketing Pioglitazone an anti-diabetes drug used in Type 2 diabetes. Pioglitazone Hydrochloride acts as an insulin sensitizer and causes the insulin receptors on cells to become more sensitive to insulin thus helping uptake of glucose and reducing their levels in the blood.It also prevents the liver from producing excess glucose. Some studies also show that it helps maintain cholesterol levels in the safe zone. It is usually prescribed once a day at strengths of 15 30 and 45 mg. The drug has certain side effects like muscle aches headache respiratory infections etc.